Ashley Wardle

Ori Biotech is a London- and Philadelphia-based leader in CGT manufacturing technology that has developed a proprietary, bespoke and flexible manufacturing platform, which enables patient access to a new generation of personalized, lifesaving treatments. By fully automating and standardizing CGT manufacturing in a closed platform, Ori offers therapeutics developers the opportunity to seamlessly scale from pre-clinical process development to commercial scale manufacturing. So complex manufacturing challenges can be put where they belong – in the past.

Ballinger Group is a specialist FX broker providing flexible and innovative foreign exchange services to corporate and institutional clients globally. Headquartered in London, Ballinger Group was established by market leading professionals to provide tailored and competitive deliverable FX solutions for sophisticated clients underserved in the market. Ballinger Group’s senior management team has over 100 years of experience at the forefront of the foreign exchange market and the business is supported by an extensive liquidity network of professional partnerships and banking arrangements. The Balinger Group comprises three distinct entities, namely, Ballinger & Co Ltd, Ballinger Europe Ltd, and Ballinger Markets Ltd. For full details on all companies within the group and their registration information please visit ballinger.group/entities.

Ori Biotech is a London- and Philadelphia-based leader in CGT manufacturing technology that has developed a proprietary, bespoke and flexible manufacturing platform, which enables patient access to a new generation of personalized, lifesaving treatments. By fully automating and standardizing CGT manufacturing in a closed platform, Ori offers therapeutics developers the opportunity to seamlessly scale from pre-clinical process development to commercial scale manufacturing. So complex manufacturing challenges can be put where they belong – in the past.